Feasibility of switching anti-tumour necrosis factor-alpha therapy in patients with rheumatois arthritis

被引：0
|
作者：
Walsh, C. A. E. [1 ]
Minnock, P. [1 ]
Slattery, C. [1 ]
Kennedy, N. [1 ]
Veale, D. J. [1 ]
Bresnihan, B. [1 ]
FitzGerald, O. [1 ]
机构：
[1] St Vincents Univ Hosp, Dept Rheumatol, Dublin, Ireland
来源：
RHEUMATOLOGY | 2006年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：I52 / I52
页数：1
相关论文
共 50 条
  • [1] SMOKING IMPACT IN THE EFFECTIVENESS OF ANTI-TUMOUR NECROSIS FACTOR-ALPHA THERAPY IN PORTUGUESE SPONDYLOARTHRITIS PATIENTS
    Aguiar, F.
    Rosa-Goncalves, D.
    Fonseca, R.
    Vieira, R.
    Madureira, P.
    Bernardo, A.
    Bernardes, M.
    Brito, I.
    Costa, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1146 - 1146
  • [2] What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?
    Feldmann, M
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1996, 111 (04) : 362 - 365
  • [3] A new adverse effect with anti-tumour necrosis factor-alpha?
    Theophile, H
    Richez, C
    Barry, MB
    Schaeverbeke, T
    Moore, N
    Haramburu, F
    [J]. DRUG SAFETY, 2005, 28 (10) : 945 - 945
  • [4] Anti-tumour necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis
    William Bilsborough
    Helen Keen
    Andrew Taylor
    Gerard J. O’Driscoll
    Leonard Arnolda
    Daniel J. Green
    [J]. Rheumatology International, 2006, 26 : 1125 - 1131
  • [5] Anti-tumour necrosis factor-alpha therapy over conventional therapy improves endothelial function in adults with rheumatoid arthritis
    Bilsborough, William
    Keen, Helen
    Taylor, Andrew
    O'Driscoll, Gerard J.
    Arnolda, Leonard
    Green, Daniel J.
    [J]. RHEUMATOLOGY INTERNATIONAL, 2006, 26 (12) : 1125 - 1131
  • [6] The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor
    Harrold, Leslie R.
    Reed, George W.
    Kremer, Joel M.
    Curtis, Jeffrey R.
    Solomon, Daniel H.
    Hochberg, Marc C.
    Greenberg, Jeffrey D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (02) : 430 - 436
  • [7] Haemophagocytic lymphohistiocytosis due to leishmaniasis following anti-tumour necrosis factor-alpha therapy
    Estabrooks, Kristen L.
    De Silva, Keshani
    Survela, Lesley
    Stevenson, William S.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2023, 203 (04) : 497 - 498
  • [8] Peripheral blood lymphocytes from patients with rheumatoid arthritis are differentially sensitive to apoptosis induced by anti-tumour necrosis factor-alpha therapy
    Coury, F.
    Ferraro-Peyret, C.
    Le Cam, S.
    Guerin, S.
    Tebib, J.
    Sibilia, J.
    Bienvenu, J.
    Fabien, N.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (02) : 234 - 239
  • [9] Clinical trial outcome of anti-tumour necrosis factor alpha therapy in rheumatic arthritis
    Choy, E
    [J]. CYTOKINE, 2004, 28 (4-5) : 158 - 161
  • [10] Anti-tumour necrosis factor alpha therapy normalises fibrinolysis impairment in patients with active rheumatoid arthritis
    Ingegnoli, F.
    Fantini, F.
    Griffini, S.
    Soldi, A.
    Meroni, P. L.
    Cugno, M.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : 254 - 257
12345